Patrick Serruys

Showing 1-20 of 533 articles

Interventions for valvular disease

Clinical Outcomes of TAVI or SAVR in Men and Women with Aortic Stenosis at Intermediate Operative Risk: a post hoc analysis of the randomized SURTAVI trial

Van Mieghem N, Reardon M, Yakubov SJ, Heiser J, Merhi W, Windecker S, Makkar R, Cheng W, Robbins M, Fail P, Feinberg E, Stoler RC, Hebeler R, Serruys P, Popma J

July 21, 2020 | 10.4244/EIJ-D-20-00303

Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein A, Sabik J, Dressler O, Mehran R, Sharma S, Stone G

June 25, 2020 | 10.4244/EIJ-D-19-00851

Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.

Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska J, Bullett N, Ahmed N, Al-Lamee K, Al-Lamee R, Leclerc G, Kitslaar P, Dijkstra J, Reiber J, Poon E, Bourantas C, Gijsen F, Serruys P, Onuma Y

June 12, 2020 | 10.4244/EIJ-D-18-01190

Coronary interventions

Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five years clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabate M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Serruys P

June 9, 2020 | 10.4244/EIJ-D-20-00024

Coronary interventions

Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys P, Hamm C, Steg P, Heg D, Branca M, Jüni P, Windecker S, Valgimigli M, Benit E, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Liebetrau C

June 2, 2020 | 10.4244/EIJ-D-20-00145

Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial

Thuijs D, Habib R, Head S, Puskas J, Taggart D, Stone G, Zhang Z, Serruys P, Sabik J, Kappetein A

May 20, 2020 | 10.4244/EIJ-D-19-00417

The SYNTAX score on its way out or … towards artificial intelligence: part I

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y

May 20, 2020 | 10.4244/EIJ-D-19-00543A

The SYNTAX score on its way out or … towards artificial intelligence: part II

May 20, 2020 | 10.4244/EIJ-D-19-00543B

Coronary interventions

The “A, B, C” of multiple statistical methods for composite endpoints

Hara H, van Klaveren D, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Takahashi K, Capodanno D, Onuma Y, Serruys P

April 28, 2020 | 10.4244/EIJ-D-19-00953

Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial

Mancone M, Cavalcante R, Modolo R, Falcone M, Biondi-Zoccai G, Frati G, Spitzer E, Benedetto U, Blackstone E, Onuma Y, van Geuns R, Diletti R, Serruys P

April 17, 2020 | 10.4244/EIJ-D-19-00208

The year in review: coronary interventions

Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns R, Capodanno D, Byrne R, Wijns W, Onuma Y, Serruys P

April 17, 2020 | 10.4244/EIJ-D-19-01124

Coronary interventions

Impact of the CABG SYNTAX Score on 10-year All-cause Death: Insights from the SYNTAX Extended Survival Study

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein AP, Head S, Onuma Y, Serruys P

April 14, 2020 | 10.4244/EIJ-D-20-00170

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabate M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg P, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

April 3, 2020 | 10.4244/EIJ-D-19-00699

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabate M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabate M, Laugwitz K, Windecker S, Kastrati A, Serruys P

March 20, 2020 | 10.4244/EIJ-D-18-01080

Coronary interventions

Absorb Bioresorbable Vascular Scaffold is Associated with Low Wall Shear Stress Compared to Xience V: A Biomechanical Analysis of the Absorb III Imaging Study.

Kumar A, Gogas B, Thompson EW, Burnett GM, Molony D, Hosseini H, Chandran K, Lefieux A, Honda Y, Lee J, Serruys P, Kereiakes DJ, Stone G, Samady H, Raad M, Gupta S, Sternheim DG, Okada K, Rapoza RJ, Simonton C, Giddens DP, Veneziani A, King III S, Ellis SG

February 23, 2020 | 10.4244/EIJ-D-19-01128

Feasibility of quantitative assessment of aortic regurgitation in a percutaneous closure of paravalvular leak: expanding videodensitometry

Teixeirense P, Modolo R, de Toledo J, Serruys P

February 20, 2020 | 10.4244/EIJ-D-19-00118

Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials?

Onuma Y, Serruys P

February 7, 2020 | 10.4244/EIJV15I15A238

Coronary interventions

Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W

February 7, 2020 | 10.4244/EIJ-D-18-00944

Coronary interventions

Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies

Stegehuis VE, Wijntjens GW, Bax M, Meuwissen M, Chamuleau SA, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef T

January 21, 2020 | 10.4244/EIJ-D-19-00774

Latest news

NEW ISSUE

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

August 7, 2020

NEW

Ahead of Print: Coronary Artery Thrombosis in COVID-19

August 7, 2020

Editorial

Coronary collaterals, the natural grafts of CTO lesions

C. Di Mario

August 7, 2020

PCR Trials

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Guidance Papers

Guidelines, consensus & position papers

June 25, 2020

Editorial

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

August 7, 2020

JAA

This Week's JAA's: Real-world Use of the Evolut PRO Valve...